- Published on:
Moscow, Jun 9 (Prensa Latina) Russian Federal Medical-Biological Agency (FMBA) chief Veronika Skvortsova announced that two vaccines for the treatment of glioblastoma, one of the most common brain tumors, could receive authorization in 2026.







